Aleva Neurotherapeutics SA

Swiss neurostimulation firm Aleva Neurotherapeutics SA has received a CE mark for its flagship product, the directSTIM deep brain stimulation (DBS) system, the company announced on 16 December. DBS

IN VITRO DIAGNOSTICS AccuraGen Inc. AccuraGen raises $40mm through Series B round AccuraGen Inc. (cancer diagnostics) raised $40mm through its Series B round from investors including Junson Ca

The field of neuromodulation has never been hotter. At the North American Neuromodulation Society (NANS) Annual Meeting in Las Vegas in December, attendance was at an all-time high, and the increasi

Deep brain stimulation (DBS) devices, on the market for 20 years, have enabled the successful treatment of more than 100,000 patients worldwide with debilitating and increasingly prevalent neurologica